Randomized, Placebo-Controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
Alan J. Gelenberg(University of Arizona), Martín Keller(University of Basel), Bruce A. Arnow, Robert H. Howland(University of Pittsburgh), Daniel N. Klein(Stony Brook University), Rachel Manber(Palo Alto University), Barbara O. Rothbaum(York College of Pennsylvania), Frances E. Borian, Phillip Banks(PredictionProbe (United States)), Melvin Munsaka, Susan G. Kornstein(Virginia Commonwealth University), John C. Markowitz(New York Psychoanalytic Society and Institute), David L. Dünner, Madhukar H. Trivedi(Southwestern Medical Center), John Zajecka(Psychiatric Medicine Associates), Michael E. Thase(Veterans Health Administration), James M. Russell(The University of Texas Medical Branch at Galveston), Ivan W. Miller(Miriam Hospital), James H. Kocsis(Cornell University), Gabor I. Keitner(Brown University), Robert M. A. Hirschfeld(The University of Texas Medical Branch at Galveston), A. John Rush(The University of Texas Southwestern Medical Center)
Cited by 78
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k